VEGFR2 Antikörper (Kinase insert Domain Receptor (A Type III Receptor tyrosine Kinase)) (AA 266-295)

Details for Product anti-KDR Antibody No. ABIN2385242
Target
Bindungsspezifität
AA 266-295, C-Term
40
34
30
20
17
16
15
13
12
12
10
9
8
8
7
7
7
7
6
5
5
5
4
4
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Reaktivität
Human
344
215
132
25
6
4
4
4
4
2
2
2
2
2
2
2
2
2
1
1
1
1
1
Wirt
Kaninchen
323
63
17
2
1
1
1
1
Klonalität
Polyklonal
Konjugat
Dieser VEGFR2 Antikörper ist unkonjugiert
37
21
17
17
13
10
10
8
8
8
8
8
3
3
3
3
3
2
2
2
2
2
1
1
Applikation
Flow Cytometry (FACS), Immunohistochemistry (IHC), ELISA
249
167
129
106
75
49
29
26
21
14
13
13
11
7
4
4
2
1
Optionen
Immunogen VEGFR2 (FLK1/KDR) antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 266~295 amino acids from the N-terminal region of human KDR.
Isotyp IgG
Kreuzreaktivität Human
Kreuzreaktivität (Details) Calculated cross reactivity: Hu
Produktmerkmale VEGFR2, CT (Vascular endothelial growth factor receptor 2, VEGFR-2, Kinase insert domain receptor, Protein-tyrosine kinase receptor Flk-1, KDR, FLK1)
Reinigung Purified by saturated ammonium sulfate precipitation followed by dialysis against PBS.
Target
Andere Bezeichnung VEGFR2 (KDR Antibody Abstract)
UniProt P35968
Pathways RTK Signalweg, Glycosaminoglycan Metabolic Process, Signaling Events mediated by VEGFR1 and VEGFR2, Growth Factor Binding, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling
Applikations-hinweise Optimal working conditions should be determined by the investigator.
Beschränkungen Nur für Forschungszwecke einsetzbar
Format Liquid
Buffer Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.
Konservierungs-mittel Sodium azide
Vorsichtsmaßnahmen This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung -20 °C
Informationen zur Lagerung -20°C